electroCore (ECOR) Non-Current Deffered Revenue (2017 - 2018)
electroCore (ECOR) posted quarterly Non-Current Deffered Revenue of $245632.0 for Q4 2018, down 19.96% year-over-year from $306886.0 in Q4 2017, and down 6.42% quarter-over-quarter from $262497.0 in Q3 2018.
electroCore (ECOR) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends
electroCore's Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $245632.0 for Q4 2018.
- In Q4 2018, Non-Current Deffered Revenue fell 19.96% year-over-year to $245632.0; the TTM figure through Dec 2018 stood at $245632.0 (down 19.96% YoY), while the FY2018 annual figure was $245632.0, down 19.96% from the prior year.
- Non-Current Deffered Revenue for Q4 2018 stood at $245632.0, down from $262497.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $306886.0 in Q4 2017, with the low at $245632.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | electroCore | 98.18 Mn | 88.13 Mn | 8.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 245,632.00 |
| Sep 30, 2018 | 262,497.00 |
| Jun 30, 2018 | 279,362.00 |
| Dec 31, 2017 | 306,886.00 |